Publications by authors named "Hannah Moyer"

Claim this Profile
T
Time Burdens for Participants With Advanced Cancer in Phase I Trials: A Cross-Sectional Study.
Renata Iskander, Adele Magnan Robart, Hannah Moyer, Ryan Nipp, Arjun Gupta

JCO Oncol Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explanation for substandard of care comparators in rheumatology randomised trial protocols.
Jacky Sheng, Andrew Zhang, Hannah Moyer, Marie Hudson, Glen Hazlewood

Lancet Rheumatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Impact of Bypassing or Overriding Phase 2 Trials in Neurologic Drug Development.
Hannah Moyer, Robyn Mellett, Karine Vigneault, Maya McKeown, Jason Karlawish

Neurology· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Benefits and Risks of Receiving Investigational Solid Tumor Drugs in Randomized Trials : A Systematic Review and Meta-analysis.
Renata Iskander, Hannah Moyer, Dean Fergusson, Sean McGrath, Andrea Benedetti

Ann Intern Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Benefit Associated With Participation in Clinical Trials of Anticancer Drugs: A Systematic Review and Meta-Analysis.
Renata Iskander, Hannah Moyer, Karine Vigneault, Salaheddin M Mahmud, Jonathan Kimmelman

JAMA· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bypassing phase 2 in cancer drug development erodes the risk/benefit balance in phase 3 trials.
Hannah Moyer, Merlin Bittlinger, Angela Nelson, Luciano Fernandez, Jacky Sheng

J Clin Epidemiol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The proportion of randomized controlled trials that inform clinical practice.
Nora Hutchinson, Hannah Moyer, Deborah A Zarin, Jonathan Kimmelman

Elife· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between lay and expert perceptions of COVID-19 vaccine development timelines in Canada and USA.
Patrick Bodilly Kane, Hannah Moyer, Amanda MacPherson, Jesse Papenburg, Brian J Ward

PLoS One· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Forecasts of COVID-19 Vaccine Development Timelines.
Patrick Bodilly Kane, Hannah Moyer, Amanda MacPherson, Jesse Papenburg, Brian J Ward

J Gen Intern Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis